Cargando…
Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing
Mucormycosis is a conditionally pathogenic fungal disease with high morbidity that mainly affects patients with decreased immunity. Diagnosis relies on the histopathological examination of microorganisms with the typical structure of mucormycetes in tissues and subsequent confirmation via culture. E...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524479/ https://www.ncbi.nlm.nih.gov/pubmed/36189372 http://dx.doi.org/10.3389/fcimb.2022.960766 |
_version_ | 1784800515705536512 |
---|---|
author | Zhang, Qing Liu, Xingchen Liu, Yanyan Wang, Huiqin Zhao, Ran Lv, Xiaodong Wei, Xudong Zhou, KeShu |
author_facet | Zhang, Qing Liu, Xingchen Liu, Yanyan Wang, Huiqin Zhao, Ran Lv, Xiaodong Wei, Xudong Zhou, KeShu |
author_sort | Zhang, Qing |
collection | PubMed |
description | Mucormycosis is a conditionally pathogenic fungal disease with high morbidity that mainly affects patients with decreased immunity. Diagnosis relies on the histopathological examination of microorganisms with the typical structure of mucormycetes in tissues and subsequent confirmation via culture. Early detection of causative microorganisms is critical to rapidly administer appropriately targeted antibiotics. Metagenomic next-generation sequencing (mNGS) is an innovative and sensitive technique used to identify pathogenic strains. Here we used mNGS to timely diagnose an infection with Lichtheimia ramosa and Mucor irregularis in two patients with hematologic malignancies; the infections manifested as nasal and cutaneous infections and developed after chemotherapy and small molecule targeted therapy. Following treatment with amphotericin B cholesteryl sulfate complex, the symptoms were reduced significantly, and both patients obtained successful outcomes. Additionally, we searched and summarized the current medical literature on the successful diagnosis of mucormycosis using mNGS. These cases indicated that mNGS, a novel culture-independent method, is capable of rapid, sensitive, and accurate identification of pathogens. mNGS may be a complementary method for the early identification of mucormycosis, allowing for appropriate and timely antibiotic administration and thus improving patient outcomes. |
format | Online Article Text |
id | pubmed-9524479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95244792022-10-01 Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing Zhang, Qing Liu, Xingchen Liu, Yanyan Wang, Huiqin Zhao, Ran Lv, Xiaodong Wei, Xudong Zhou, KeShu Front Cell Infect Microbiol Cellular and Infection Microbiology Mucormycosis is a conditionally pathogenic fungal disease with high morbidity that mainly affects patients with decreased immunity. Diagnosis relies on the histopathological examination of microorganisms with the typical structure of mucormycetes in tissues and subsequent confirmation via culture. Early detection of causative microorganisms is critical to rapidly administer appropriately targeted antibiotics. Metagenomic next-generation sequencing (mNGS) is an innovative and sensitive technique used to identify pathogenic strains. Here we used mNGS to timely diagnose an infection with Lichtheimia ramosa and Mucor irregularis in two patients with hematologic malignancies; the infections manifested as nasal and cutaneous infections and developed after chemotherapy and small molecule targeted therapy. Following treatment with amphotericin B cholesteryl sulfate complex, the symptoms were reduced significantly, and both patients obtained successful outcomes. Additionally, we searched and summarized the current medical literature on the successful diagnosis of mucormycosis using mNGS. These cases indicated that mNGS, a novel culture-independent method, is capable of rapid, sensitive, and accurate identification of pathogens. mNGS may be a complementary method for the early identification of mucormycosis, allowing for appropriate and timely antibiotic administration and thus improving patient outcomes. Frontiers Media S.A. 2022-09-16 /pmc/articles/PMC9524479/ /pubmed/36189372 http://dx.doi.org/10.3389/fcimb.2022.960766 Text en Copyright © 2022 Zhang, Liu, Liu, Wang, Zhao, Lv, Wei and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Zhang, Qing Liu, Xingchen Liu, Yanyan Wang, Huiqin Zhao, Ran Lv, Xiaodong Wei, Xudong Zhou, KeShu Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing |
title | Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing |
title_full | Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing |
title_fullStr | Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing |
title_full_unstemmed | Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing |
title_short | Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing |
title_sort | nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: early detection by metagenomic next-generation sequencing |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524479/ https://www.ncbi.nlm.nih.gov/pubmed/36189372 http://dx.doi.org/10.3389/fcimb.2022.960766 |
work_keys_str_mv | AT zhangqing nasalandcutaneousmucormycosisintwopatientswithlymphomaafterchemotherapyandtargettherapyearlydetectionbymetagenomicnextgenerationsequencing AT liuxingchen nasalandcutaneousmucormycosisintwopatientswithlymphomaafterchemotherapyandtargettherapyearlydetectionbymetagenomicnextgenerationsequencing AT liuyanyan nasalandcutaneousmucormycosisintwopatientswithlymphomaafterchemotherapyandtargettherapyearlydetectionbymetagenomicnextgenerationsequencing AT wanghuiqin nasalandcutaneousmucormycosisintwopatientswithlymphomaafterchemotherapyandtargettherapyearlydetectionbymetagenomicnextgenerationsequencing AT zhaoran nasalandcutaneousmucormycosisintwopatientswithlymphomaafterchemotherapyandtargettherapyearlydetectionbymetagenomicnextgenerationsequencing AT lvxiaodong nasalandcutaneousmucormycosisintwopatientswithlymphomaafterchemotherapyandtargettherapyearlydetectionbymetagenomicnextgenerationsequencing AT weixudong nasalandcutaneousmucormycosisintwopatientswithlymphomaafterchemotherapyandtargettherapyearlydetectionbymetagenomicnextgenerationsequencing AT zhoukeshu nasalandcutaneousmucormycosisintwopatientswithlymphomaafterchemotherapyandtargettherapyearlydetectionbymetagenomicnextgenerationsequencing |